Literature DB >> 31378897

LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.

T Liu1, J-J Zuo, F Li, Y-C Xu, A-Y Zheng, Z-Z Tao.   

Abstract

OBJECTIVE: We aimed at elucidating the potential function of long noncoding ribonucleic acids (lncRNAs) small nucleolar RNA host gene 1 (SNHG1) in the progression of laryngeal cancer (LC) and its underlying mechanism. PATIENTS AND METHODS: Relative level of SNHG1 in LC tissues and controls was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Its expression in LC patients with different tumor stages and statues of lymph node metastasis was examined as well. Correlation between SNHG1 expression and prognosis of LC patients was evaluated by the Kaplan-Meier method. SNHG1 siRNA (si-SNHG1) was constructed for downregulation of SNHG1 expression. Potential effects of downregulated SNHG1 on viability and proliferation of LC cells were detected by cell counting kit-8 (CCK-8) and colony formation assay, respectively. After knockdown of SNHG1, relative levels of Notch1 and hairy, and enhancer of split homolog-1 (Hes1) were determined by qRT-PCR and Western blot. Regulatory effects of SNHG1/Notch1 axis on biological behaviors of LC were finally evaluated.
RESULTS: SNHG1 was upregulated in LC tissues than that of controls. Besides, its level was higher in LC with T3-T4 relative to those of T1-T2. Higher abundance of SNHG1 was identified in LC patients with lymph node metastasis compared with those non-metastatic patients. Survival analysis indicated that LC patients with high-level SNHG1 had worse overall survival. Knockdown of SNHG1 in Tu212 and Hep2 cells downregulated relative levels of Notch1 and Hes1. Moreover, SNHG1 knockdown resulted in decreased viability and proliferative ability of LC cells. Notch1 overexpression could reverse the regulatory effects of SNHG1 on viability and proliferation of LC cells.
CONCLUSIONS: LncRNA SNHG1 is highly expressed in LC tissues. It promotes the proliferation of LC cells by inhibiting Notch1 pathway, thereby promoting the progression of LC.

Entities:  

Year:  2019        PMID: 31378897     DOI: 10.26355/eurrev_201908_18542

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Long non-coding RNA SNHG1/microRNA-195-5p/Yes-associated protein axis affects the proliferation and metastasis of gastric cancer via the Hippo signaling pathway.

Authors:  Fahui Cheng; Li Wang; Shengen Yi; Ganglei Liu
Journal:  Funct Integr Genomics       Date:  2022-07-12       Impact factor: 3.674

2.  lncRNA SNHG1 Promotes Progression of Cervical Cancer Through miR-195/NEK2 Axis.

Authors:  Yuan Yuan Ji; Man Meng; Ye Miao
Journal:  Cancer Manag Res       Date:  2020-11-09       Impact factor: 3.989

3.  Identification of m6A-Related lncRNA to Predict the Prognosis of Patients with Hepatocellular Carcinoma.

Authors:  Hao Yang; Hong Yang; Wei Zhang; Juping Wang; Liping Sun; Juan Gao; Haiping Zhao; Zhenfei Wang
Journal:  Biomed Res Int       Date:  2022-05-09       Impact factor: 3.246

4.  LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis.

Authors:  Zhi-Qi Liu; Wei-Feng He; Yang-Jie Wu; Shun-Li Zhao; Ling Wang; Yan-Yi Ouyang; San-Yuan Tang
Journal:  BMC Gastroenterol       Date:  2020-05-18       Impact factor: 3.067

5.  SNHG1 represses the anti-cancer roles of baicalein in cervical cancer through regulating miR-3127-5p/FZD4/Wnt/β-catenin signaling.

Authors:  Xiaolan Yu; Jiyi Xia; Yong Cao; Li Tang; Xiaoping Tang; Zhengyu Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-03

6.  MiR-137 inhibits cervical cancer progression via down-modulating Notch1 and inhibiting the PI3K/AKT/mTOR signaling pathway.

Authors:  Ying Gui; Lina Wang; Zhihong Huang
Journal:  Transl Cancer Res       Date:  2021-08       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.